HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kinetics of a putative hypoxic tracer, 99mTc-HL91, in normoxic, hypoxic, ischemic, and stunned myocardium.

AbstractUNLABELLED:
99mTc-4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime (HL91) was developed as a putative hypoxic reagent. This study focused on the myocardial kinetics of 99mTc-HL91 in various oxygen levels and perfusion states.
METHODS:
The time-activity curve of 99mTc-HL91 was measured in isolated perfused rat heart after the bolus infusion.
RESULTS:
99mTc-HL91 was cleared quickly from normoxic hearts, and retention at 30 min after injection was 0.18 +/- 0.02 percentage injected dose per gram of wet weight (mean +/- SE; n = 6). When the concentration of oxygen bubbling through the perfusate was reduced from 100% to 50%, 20%, 5%, and 0%, retention of 99mTc-HL91 increased to 0.47 +/- 0.03 (n = 5), 0.48 +/- 0.03 (n = 5), 0.71 +/- 0.01 (n = 5), and 0.70 +/- 0.02 (n = 5), respectively (P < 0.05). Compartment analysis revealed that the trapping mechanism, which was dependent on tissue oxygen concentration, determined the retention rate. Although not retained in stunned myocardium (0.17 +/- 0.02, n = 5; P = not significant), 99mTc-HL91 was significantly retained when injected before ischemia (1.06 +/- 0.06, n = 5; P < 0.05).
CONCLUSION:
These results indicate that retention of 99mTc-HL91 correlates well with oxygen level in the perfusate, suggesting that the agent may be a useful marker of the severity of myocardial hypoxia.
AuthorsK Imahashi, K Morishita, H Kusuoka, Y Yamamichi, S Hasegawa, K Hashimoto, Y Shirakami, M Kato-Azuma, T Nishimura
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 41 Issue 6 Pg. 1102-7 (Jun 2000) ISSN: 0161-5505 [Print] United States
PMID10855642 (Publication Type: Journal Article)
Chemical References
  • Organotechnetium Compounds
  • Oximes
  • technetium Tc 99m 4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime
Topics
  • Animals
  • Heart (diagnostic imaging)
  • Hypoxia (diagnostic imaging, metabolism)
  • In Vitro Techniques
  • Male
  • Myocardial Ischemia (diagnostic imaging)
  • Myocardial Stunning (diagnostic imaging)
  • Myocardium (metabolism)
  • Organotechnetium Compounds (pharmacokinetics)
  • Oximes (pharmacokinetics)
  • Oxygen Consumption
  • Radionuclide Imaging
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: